5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 11.13▲ | 11.10▲ | 10.93▲ | 10.81▲ | 8.03▲ |
MA10 | 11.11▲ | 10.73▲ | 10.26▲ | 9.96▲ | 6.32▲ |
MA20 | 10.74▲ | 9.96▲ | 9.81▲ | 7.60▲ | N/A |
MA50 | 9.69▲ | 10.38▲ | 9.98▲ | 5.94▲ | N/A |
MA100 | 10.34▲ | 9.70▲ | 8.17▲ | N/A | N/A |
MA200 | 9.96▲ | 7.46▲ | 6.75▲ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.019▲ | 0.222▲ | 0.231▲ | 0.275▲ | N/A |
RSI | 61.756▲ | 62.607▲ | 58.998▲ | 60.334▲ | 77.679▲ |
STOCH | 65.895 | 86.423▲ | 92.377▲ | 64.864 | N/A |
WILL %R | -17.857▲ | -7.258▲ | -7.258▲ | -28.523 | -27.829 |
CCI | 70.887 | 96.470 | 116.375▲ | 90.631 | 201.602▲ |
Thursday, April 24, 2025 05:00 PM
Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research ...
|
Thursday, April 24, 2025 05:00 PM
Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research ...
|
Tuesday, April 22, 2025 07:39 AM
Financials are currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 10.97 | 11.50 | 10.60 | 11.275 | 161,995 |
01/05/25 | 9.00 | 10.8963 | 8.20 | 10.43 | 424,569 |
30/04/25 | 9.06 | 10.00 | 8.05 | 9.11 | 407,200 |
29/04/25 | 13.75 | 14.03 | 7.325 | 9.07 | 1,486,680 |
28/04/25 | 10.215 | 14.25 | 10.215 | 14.15 | 361,651 |
25/04/25 | 10.10 | 12.46 | 9.50 | 10.44 | 599,400 |
24/04/25 | 7.70 | 10.55 | 7.70 | 10.55 | 745,900 |
23/04/25 | 8.30 | 10.00 | 5.066 | 7.82 | 1,716,600 |
22/04/25 | 7.91 | 9.36 | 6.66 | 9.01 | 1,346,400 |
21/04/25 | 9.90 | 11.20 | 6.55 | 7.70 | 575,200 |
|
|
||||
|
|
||||
|
|